These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22306327)

  • 1. The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.
    Martínez-García MA; San-Millán JL; Escobar-Morreale HF
    Gene; 2012 Apr; 497(1):38-44. PubMed ID: 22306327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.
    San Millán JL; Botella-Carretero JI; Alvarez-Blasco F; Luque-Ramírez M; Sancho J; Moghetti P; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4157-62. PubMed ID: 15827106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.
    Draper N; Powell BL; Franks S; Conway GS; Stewart PM; McCarthy MI
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):64-70. PubMed ID: 16817821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H6PD Gene Polymorphisms (R453Q and D151A) and Polycystic Ovary Syndrome: A Case-Control Study in A Population of Iranian Kurdish Women.
    Naseri R; Alimoradi Y; Sohrabi M; Cheraghian Fard M; Barzingarosi E; Abdolmaleki A; Jalili C
    Int J Fertil Steril; 2022 Aug; 16(3):180-183. PubMed ID: 36029054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome.
    Qin K; Rosenfield RL
    Steroids; 2011 Jan; 76(1-2):135-9. PubMed ID: 21050867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
    Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
    Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.
    Valkenburg O; Uitterlinden AG; Themmen AP; de Jong FH; Hofman A; Fauser BC; Laven JS
    Hum Reprod; 2011 Oct; 26(10):2902-11. PubMed ID: 21803757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population.
    Ju R; Wu W; Tang Q; Wu D; Xia Y; Wu J; Wang X
    PLoS One; 2015; 10(10):e0140326. PubMed ID: 26452272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample.
    White PC
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5880-3. PubMed ID: 16091483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia.
    Marioli DJ; Koika V; Adonakis GL; Saltamavros AD; Karela A; Armeni AK; Tsapanos VS; Decavalas GO; Georgopoulos NA
    Arch Gynecol Obstet; 2010 Jun; 281(6):1045-9. PubMed ID: 20012307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione.
    Panidis D; Kourtis A; Kukuvitis A; Farmakiotis D; Xita N; Georgiou I; Tsatsoulis A
    Hum Reprod; 2004 Aug; 19(8):1728-33. PubMed ID: 15178661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of 11β-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects.
    Li S; Tao T; Wang L; Mao X; Zheng J; Zhao A; Liu W
    Horm Metab Res; 2013 Oct; 45(11):802-7. PubMed ID: 23979790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.
    Escobar-Morreale HF; Villuendas G; Botella-Carretero JI; Alvarez-Blasco F; Sanchón R; Luque-Ramírez M; San Millán JL
    Hum Reprod; 2006 Sep; 21(9):2257-65. PubMed ID: 16675483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants of insulin action in polycystic ovary syndrome.
    Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
    Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.